BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tziomalos K. Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B. World J Hepatol 2010; 2(3): 91-93 [PMID: 21160979 DOI: 10.4254/wjh.v2.i3.91]
URL: https://www.wjgnet.com/1948-5182/full/v2/i3/91.htm
Number Citing Articles
1
Enze Jiang, Anna Junjie Shangguan, Shuangshuang Chen, Lin Tang, Shuang Zhao, Zhenghong Yu. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinomaCancer Letters 2016; 379(2): 262 doi: 10.1016/j.canlet.2015.07.016
2
Chih-Lang Lin, Rong-Nan Chien, Charisse Yeh, Chao-Wei Hsu, Ming-Ling Chang, Yi-Cheng Chen, Chau-Ting Yeh. Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case–control studyScandinavian Journal of Gastroenterology 2014; 49(12): 1456 doi: 10.3109/00365521.2014.962604
3
Natravis Cox, Hans Tillmann. Emerging pipeline drugs for hepatitis B infectionExpert Opinion on Emerging Drugs 2011; 16(4): 713 doi: 10.1517/14728214.2011.646260
4
Jing He, James M. Bowen, Feng Xie, Ron Goeree. Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in CanadaValue in Health 2012; 15(6): 894 doi: 10.1016/j.jval.2012.06.005
5
Cheng-Zhang Wang, Wen-Jun Li, Ran Tao, Jian-Zhong Ye, Hong-Yu Zhang. Antiviral Activity of a Nanoemulsion of Polyprenols from Ginkgo Leaves against Influenza A H3N2 and Hepatitis B Virus in VitroMolecules 2015; 20(3): 5137 doi: 10.3390/molecules20035137
6
William C. Chapman, Robert L. Galloway. Intraoperative Imaging and Image-Guided Therapy2014; : 779 doi: 10.1007/978-1-4614-7657-3_59